Dietary Supplements Industry in Indonesia: Market Overview & Outlook 2026-2030

Market Overview

Walk into any Indomaret in Jakarta and you will find a shelf of supplements next to the cashier: energy sachets, immune boosters, gummies for children. Open Shopee and the choice runs into thousands of listings, from Australian fish oil to local turmeric blends and Korean collagen drinks. Since the pandemic, dietary supplements have moved from something people took when they felt unwell to a daily habit for many urban Indonesians. That shift is why so many founders, investors and brand owners are now asking whether there is room for one more supplement business.

We estimate retail sales of dietary supplements at about IDR 17.3 trillion in 2025, or roughly USD 1.06 billion at IDR 16,400 per dollar. Sales rose 4.2% on 2024 and 5.8% a year on average since 2020. Spread across 284.67 million people, that is about IDR 60,800 per person per year, up from around IDR 48,300 in 2020. These totals cover supplements only. Single and multivitamins, registered jamu and herbal medicines, protein powders sold as food and functional drinks are separate categories, although they compete for the same household budget.

The shape of the curve matters for anyone building a business plan. Growth was strongest in 2020 and 2021, when COVID-19 turned immunity products into essentials. It then slowed to under 4% in 2023 as pandemic buying faded and household budgets came under pressure. Since 2024 the market has settled into steady growth of around 4-5% a year in current prices, or about 2-3% after inflation. In other words, this is a growing market, but not one where a rising tide will carry every new brand.

The early signs for 2026 are mixed. Online sales of healthcare products are still growing quickly, but the large listed makers have had a weaker year: Sido Muncul's sales fell 8.4% in the first nine months of 2026. Our nowcast puts 2026 growth at around 5.5%, with most of the gain coming from online channels and newer brands rather than from the established names.

Segmentation: What Indonesians Buy

The market splits into two families. Non-herbal supplements, such as probiotics, calcium, fish oil and multi-ingredient formulas, make up about 68% of value and have grown about 7% a year since 2020. Herbal and traditional supplements, such as ginseng, garlic, echinacea, aloe and herbal blends, account for the remaining 32% and have grown much more slowly, at about 3% a year. Part of the reason is that much of Indonesia's herbal spending goes to registered jamu and herbal medicines rather than to products registered as supplements.

Two things stand out. First, probiotics have become the single largest product type, helped by growing awareness of gut health and the frequent stomach complaints of stressed city workers. Second, herbal blends that mix turmeric, ginger or ginseng with vitamins are growing as fast as probiotics. Sido Muncul, Deltomed's Herbana and Herbilogy are all active here. Single-herb products such as aloe, by contrast, are shrinking.

Looking at the reason people buy, rather than the ingredient, the picture is changing faster. Products for women's health rose from about 10% of value in 2020 to around 14% in 2025, and immunity products from about 12% to 14%. General health products, the old multivitamin-style positioning, are slowly losing share. For a new brand, this points to a clear lesson: products that solve a named problem sell better than products that promise to make you generally healthier.

Who Buys Supplements and Why

The core buyers are working adults aged roughly 25 to 45 in cities and larger towns, who use supplements to deal with stress, fatigue, digestion and immunity. A YouGov survey of Indonesian adults conducted between December 2025 and January 2026 found that 80% took at least one supplement. Vitamins were by far the most common, followed by herbal supplements, omega-3, collagen and probiotics.

Health data explains part of the demand. The Ministry of Health's 2023 Indonesian Health Survey (SKI) found high blood pressure in 30.8% of adults and diabetes, measured by blood test, in 11.7% of people aged 15 and over. The ministry has also said that nearly one in five Indonesians over 50 has osteoporosis. These figures support demand for heart, blood-sugar and calcium products, and they will grow with an ageing population.

Income is the brake. BPS data processed by Mandiri Institute shows the middle class shrinking from 47.9 million people in 2024 to 46.7 million in 2025, while the aspiring middle class grew to 142 million, about half the population. More people want to buy supplements, but many have less to spend on each purchase. That favours small packs, sachets and affordable price points over premium imported jars. Our earlier study of Indonesian purchasing power covers this trend in more detail.

Distribution Channels

Pharmacies remain the most important channel. Shoppers trust pharmacists for first purchases and premium products, and chains such as Kimia Farma, Century and K-24 give national reach. But the share of sales going online has roughly doubled since 2020. Marketplaces such as Shopee and Tokopedia, health apps such as Halodoc and KlikDokter, and social commerce through TikTok Shop, Instagram and WhatsApp are now where most new brands are born. Compas data shows healthcare product sales on Indonesian marketplaces grew 24.4% in the first half of 2026.

Channel choice has practical consequences for the plan. Selling into pharmacies normally means working with a licensed pharmaceutical wholesaler (PBF) or a distributor that has one, accepting listing fees and long payment terms, and keeping enough stock in the system to avoid empty shelves. Selling online means paying marketplace commissions and, in practice, a steady advertising budget to stay visible. Minimarkets reach the mass market fastest but favour well-known brands at low price points. Most new brands start online, prove repeat purchase, and only then approach pharmacy chains.

Direct selling deserves a mention because it is larger in Indonesia than in many markets. Brands such as K-Link, Herbalife and Amway's Nutrilite together hold around 12% of the market. Their share has fallen since 2021, however, as members and customers move to marketplaces where prices are easy to compare.

Regulatory Requirements for a New Supplement Business

This is the section most feasibility studies get wrong, so it is worth being precise. In Indonesia, a health supplement (suplemen kesehatan) is a regulated product class under the Food and Drug Authority, BPOM. It is different from a drug, a herbal medicine and a processed food. The class decides how you register the product, which factory can make it and what you can say on the label.

The good news for founders is that you do not need your own factory. BPOM allows three registration routes: production by the applicant itself, production under contract (maklon) by a certified manufacturer on behalf of a brand owner, or production under licence from a foreign brand. Most new brands use the contract route, which turns factory investment into a cost per unit. The process runs online through BPOM's Asrot system, with a pre-registration step that sets the product category and fee.

Halal deserves a separate line in any project plan. Certification covers the whole chain: each ingredient, the capsule shell (gelatin or plant-based), processing aids and the manufacturer's facility. A contract manufacturer that already holds halal certification for similar products shortens the process considerably. The association APSKI, which has about 100 members, said in 2026 that most of its members were prepared for the mandate.

Enforcement is also getting tougher. In 2025 BPOM found 197,725 illegal or non-compliant online listings of drugs and food, including 15,949 for supplements. Slimming and stamina products spiked with drugs such as sibutramine and tadalafil were among the top cases. For a legitimate business, this is a plus: it removes some of the cheapest unregistered competition.

Competitive Landscape

Indonesia's supplement market is unusually fragmented. The leader, Tempo Scan Pacific, holds about 8.6% of value, mostly through Hemaviton. The top ten companies together hold only about 32%. The remaining two-thirds is spread across hundreds of smaller brands, and that share has grown from about 61% in 2021 to 68% in 2025 as small online brands multiplied.

Online, the ranking looks quite different. Compas data for beauty supplements on Shopee in the first quarter of 2025 shows Natur-E in first place with a 12% share, followed by Cool-Vita, Noera by Reisha, Meprothion and Blackmores. Only Blackmores also appears among the market-wide leaders. This gap is where new brands find room: online categories are led by brands built on beauty, skincare and social media, not by the old pharmacy names. If you are looking at beauty-from-within products, our reports on the beauty and personal care industry and the skincare and cosmetics market are useful companions.

Key Players in Brief

Several of the leaders are listed on the Indonesia Stock Exchange, and their results give a useful read on the health of the business. The numbers below are for whole companies, so supplements are only part of each figure.

Two signals matter for a new entrant. Sido Muncul earns a net margin of about 30%, which shows how profitable a trusted brand with its own plant can be. But Tempo Scan's profit fell in 2025 as selling costs rose 8.8%, and Sido Muncul's sales dropped in 2026. Even the leaders are spending more to hold their position. In this market, the cost of winning customers, not the cost of ingredients, decides who makes money.

Using This Data in a Feasibility Study

If you are testing whether a supplement business can work in Indonesia, the question is rarely whether there is demand. There is. The questions are whether your product can be registered on time and on budget, which channel you can win first, and whether you can reach customers at a cost that leaves a margin. The table below maps the usual feasibility study chapters to the evidence in this article and in the full report.

What this article does not cover is the forward view. The full report adds an indicative cost and margin structure, a Porter's Five Forces assessment, mega trends, five company profiles and bear, base and bull forecasts to 2030, together with a comparison of entry routes from contract manufacturing to an own CPOTB plant. For readers interested in adjacent food categories, our article on future food trends in Indonesia looks at the wider health and wellness shift.

Dietary Supplements Industry in Indonesia Executive Summary

The three slides below summarise the full report. The complete 40-slide version, with the outlook to 2030, value chain, entry routes and company profiles, is available on Gumroad.

What the Full Report Includes